Corcept Therapeutics, Inc. (CORT)
116.23
+2.20
(+1.93%)
USD |
NASDAQ |
Oct 02, 16:00
116.23
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Profit Margin (Quarterly) : 16.45% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.45% |
| March 31, 2026 | -18.92% |
| December 31, 2025 | 11.83% |
| September 30, 2025 | 9.32% |
| June 30, 2025 | 17.80% |
| March 31, 2025 | 12.90% |
| December 31, 2024 | 16.71% |
| September 30, 2024 | 25.58% |
| June 30, 2024 | 21.44% |
| March 31, 2024 | 18.74% |
| December 31, 2023 | 23.00% |
| September 30, 2023 | 25.22% |
| June 30, 2023 | 23.24% |
| March 31, 2023 | 14.96% |
| December 31, 2022 | 16.04% |
| September 30, 2022 | 33.96% |
| June 30, 2022 | 26.51% |
| March 31, 2022 | 24.33% |
| December 31, 2021 | 32.44% |
| September 30, 2021 | 31.70% |
| June 30, 2021 | 28.96% |
| March 31, 2021 | 29.54% |
| December 31, 2020 | 30.32% |
| September 30, 2020 | 25.05% |
| June 30, 2020 | 31.98% |
| Date | Value |
|---|---|
| March 31, 2020 | 32.24% |
| December 31, 2019 | 33.43% |
| September 30, 2019 | 32.32% |
| June 30, 2019 | 27.94% |
| March 31, 2019 | 28.19% |
| December 31, 2018 | 32.93% |
| September 30, 2018 | 27.54% |
| June 30, 2018 | 29.20% |
| March 31, 2018 | 30.28% |
| December 31, 2017 | |
| September 30, 2017 | 32.17% |
| June 30, 2017 | 35.57% |
| March 31, 2017 | 15.90% |
| December 31, 2016 | 19.31% |
| September 30, 2016 | 11.90% |
| June 30, 2016 | 4.95% |
| March 31, 2016 | -0.12% |
| December 31, 2015 | 6.41% |
| September 30, 2015 | -4.53% |
| June 30, 2015 | -16.19% |
| March 31, 2015 | -47.81% |
| December 31, 2014 | -43.22% |
| September 30, 2014 | -82.48% |
| June 30, 2014 | -129.1% |
| March 31, 2014 | -316.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 30.88% |
| Pfizer Inc. | -1.64% |
| Aclaris Therapeutics, Inc. | -1.32K% |
| Bristol Myers Squibb Co. | 25.54% |
| Liquidia Corp. | 43.52% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.32% |
| Return on Assets | 6.50% |
| Return on Invested Capital | 8.22% |
| Gross Profit Margin (Quarterly) | 98.41% |
| Operating Margin (Quarterly) | 16.12% |
| Return on Net Operating Assets | 52.69% |